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The trophoblast is a fetal-derived tissue located at the interface between the fetus and the maternal circulation. It develops from the inner layer of young proliferative cells, called cytotrophoblasts, from which originates the outer layer ofsyncytiotrophoblasts that are in direct contact with the maternal circulation. Trophoblast cells sometimes give rise to tumors called choriocarcinomas.
The passage of fetal nucleated cells into the mother has been documented, such cells having been detected in maternal blood samples either directly (1) or after enrichment with a fluorescence-activated cell sorter (FACS) (2, 3). The histological type of these cells, however, has not been determined, and it is not known whether they form a homogenous population. The proximity of trophoblast cells to mothers' blood makes them good candidates for at least some of the fetal cells found in maternal circulation and, indeed, syncytiotrophoblast cells have been observed in maternal lungs (4) . Much smaller cytotrophoblast cells might not be trapped in the lung capillary network and would continue to circulate. Specific antibodies to trophoblasts could be used to identify FACS-sorted cells or as fluorescent reagents to label them so they can be separated with the FACS. Xenogeneic antisera have been raised to human trophoblast cells (5), but using these for isolating rare trophoblasts from maternal blood cells is greatly hampered by their evident complexity, which requires that they be extensively absorbed.
The emergence of hybridoma technology, which overcomes the technical limitations of conventional serology (6), has permitted us to raise monoclonal antibodies to human trophoblast cells. This communication deals with the generation and characterization of a series of such monoclonal antibodies to various antigens expressed on normal and malignant trophoblast cells. Four Production of Monoclonal Antibodies. Two BALB/cN female mice were immunized and boosted 3 weeks later with 106 cells of the BeWo choriocarcinoma cell line injected intraperitoneally. Three days after the boost, spleen cells were harvested and fused to NS-1 myeloma cells as described (7) Initial Screening of Hybrid Production and Cloning. On the 11th day after the fusion, all 150 cultures showed growth. Culture supernates were harvested and screened for antibodies to the immunizing BeWo cell line by using a radioimmunoassay; 2 x 104 BeWo cells were plated in wells of microtiter plates (Costar, Division of Data Packaging, Cambridge, MA), and allowed to adhere to the plastic overnight, and then washed with radioimmunoassay buffer. The cells were incubated for 1 hr with 20 ,ul of supernate and then washed three times. AntiBeWo antibodies were detected by adding, for 1 hr, 30,000 cpm of an "2I-labeled goat anti-mouse immunoglobulin antiserum absorbed on a human immunoglobulin immunosorbent. Incubations were at room temperature. After three more washes, the cells were lysed in the presence of 1% Nonidet D. The lysates were harvested with a cotton tip swab and assayed in a gamma scintillation counter (Micromedic Systems, Division of Rohm and Haas, Philadelphia, PA). Individual viable cells from positive cultures of interest were directly deposited into microculture wells with the FACS. In a previous report (8) , the FACS was used to sort individual hybrids on the basis of their binding of fluorescent microspheres coupled with antigen. In the present case, however, the cells were selected on the basis of viability only. Growing clones were tested 1 week later for production of the desired monoclonal antibody. Monoclonal antibody isotypes were determined by reaction with mouse allotype-specific I-labeled monoclonal antibodies (9 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 5147 sons independent of this study. Normal liver, kidney, spleen, thymus, and lymph nodes were obtained from portions of surgical specimens not required for pathologic examination. Tissue was frozen, cut, and stained as described (13) except that the last stage applied was peroxidase-coupled rabbit anti-mouse immunoglobulin (Dako, distributed by Accurate Chemical and Scientific, Hicksville, NY), which was followed by diaminobenzidine (Sigma) at 1 mg/ml in phosphate-buffered saline with 10 A1 of30% H202 per ml. After a 2-min incubation, the slides were washed, incubated with 0.5% CuS04 in isotonic saline for 5 min, washed, dehydrated, and mounted in Permabond. Formalin-fixed paraffin-embedded placenta was stained in the same way. Undiluted hybridoma culture supernates were used for this staining. RESULTS We examined the cellular reactivity of six distinct anti-BeWo monoclonal antibodies by indirect immunofluorescence staining and FACS analysis using a series of human tumor and lymphoid cell lines and normal peripheral blood mononuclear cells (Table 1) . Three antibodies, 162-10.2, 162-28.2, and 162-43. 4 , stained all cell lines tested, as well as blood lymphocytes and monocytes. However, these antibodies detect two different antigens; distinct peripheral blood lymphocyte FACS staining profiles were obtained with 162-10.2 on the one hand and with 162-28.2 and 162-43.4 on the other hand (Fig. 1) . The FACS staining profiles on all cells tested with 162-28.2 and 162-43.4 were similar. As each antibody also blocked the staining of the target with the other (Table 2) , both antibodies probably react with the same or proximal determinants of the same antigenic molecule. This antigen, called Trop4, does not distinguish lymphocyte subpopulations. In contrast, Trop-3, detected by 162-10.2, is present on about half of the lymphocytes with a considerably higher density than on the other half (Fig. 1) .
The other three monoclonal antibodies appear to be trophoblast-specific (Table 1) Table 2) . Trop-1 is present on all four choriocarcinoma cell lines and also, at a much lower density, on the fibrosarcoma and the K562 cell lines. It is absent from normal blood cells and various other tumor cell lines ( Table 1 ). The expression of Trop-2 is restricted to three ofthe four choriocarcinoma cell lines. (Table 1 ). It could not be detected on any ofthe other normal or tumor cells tested.
Sections of placenta were stained with all six monoclonal antibodies and with 11-4.1, a mouse immunoglobulin (of 2a subclass) that does not react with human tissues as a control. All four Trop antigens were detectable on both frozen and fixed paraffin-embedded sections. Fig. 2 antigens appeared to be virtually restricted to cells of trophoblast origin as they reacted only with normal trophoblast cells and choriocarcinomas, with the exceptions of the fibrosarcoma cell line HT1080C and the erythroleukemia cell line K562, which expressed a low density ofTrop-1. Conversely, monoclonal antibodies to Trop-3 and Trop4 antigens displayed a wide range of reactivity and were positive with various solid tumor and lymphoid cell lines and with normal nucleated peripheral blood cells. Interestingly, FACS analysis ofimmunofluorescent staining showed that, whereas Trop-4 was homogenously distributed, Trop-3 on the contrary was not evenly expressed. on peripheral blood lymphocytes and monocytes; about one-half of the total lymphocyte and monocyte populations expressed a higher antigen density (as much as a 4-fold effect in some individuals) than the other half.
In previously reported studies with xenogeneic antitropho blast antisera, trophoblast surface antigens were classified into two major groups (5 The function these antigens fulfill at the surface oftrophoblast and other cells is currently unknown. In this regard, it is noteworthy that among the six monoclonal antibodies, only the two anti-Trop4 antibodies added to the culture medium of a mixed lymphocyte, reaction inhibit the allogeneically stimulated proliferation.
We foresee several possible clinical applications for trophoblast-specific reagents such as the anti-Trop-1 and anti-Trop-2 monoclonal antibodies described here. They could be used to investigate the passage of fetal trophoblast cells into maternal circulation during pregnancy and, if present, to sort them with a FACS for possible prenatal diagnostic use. They could also be coupled to radionuclide probes to detect and then deliver local irradiation to primary tumors and metastases in patients with. choriocarcinomas and'other germ-cell neoplasms.. They might also be able to immunologically target cytotoxic agents coupled to the antibodies or antibody fragments as has been described (14, 15) . Finally, studies performed in the rat have indicated that xenogeneic antitrophoblast antisera, when injected into mated female rats after being absorbed with lymphoid cells, showed an abortifacient activity (16) . Thus, the anti-Trop-1 and antiTrop-2 monoclonal antibodies described here could have useful investigative, diagnostic, and therapeutic applications.
